Dr. Patrick Vincent Acevedo, MD

Dr. Acevedo practices at HCA Florida West Marion Hospital, a Part of HCA Florida Ocala Hospital in Ocala, Florida.

Dr. Acevedo's NPI, 1639132269, was assigned on April 6, 2006. Dr. Acevedo graduated from Sidney Kimmel Medical College in 1998. Dr. Acevedo holds Florida license ME90036.

Dr. Acevedo's primary practice is HCA Florida West Marion Hospital, a Part of HCA Florida Ocala Hospital, at 4600 Sw 46th Ct, Ocala, FL 34474 in Marion County. The practice phone is (352) 291-6401.

Dr. Acevedo's primary practice is HCA Florida West Marion Hospital, a Part of HCA Florida Ocala Hospital in Ocala, Florida. Dr. Acevedo is also affiliated with HCA Florida Ocala Hospital. The medical group on file is CORA Physical Therapy, Spanish Springs. Dmand AI also links Dr. Acevedo to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Acevedo practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Acevedo's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Acevedo is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Acevedo's licenses on file in 2 states: Florida and New Jersey.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Acevedo treats.

CMS data shows 180,603 Medicare services from Dr. Acevedo across 59 procedure codes in 2024, for 1,281 Medicare patients. Medicare paid $1,677,659 for them.

CMS counts 1,281 Medicare patients who saw Dr. Acevedo in 2024. The largest group is 75 to 84, with 630 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Acevedo's median patient age at 71, with 61% women.

In 2024, Dr. Acevedo wrote 2,153 Medicare Part D claims for 467 patients. 69% of them were for generic drugs. CMS names the drug for 1,728 of them, across 52 drugs with 11 or more claims each, at $5,918,961 in total drug cost. In 2023, CMS named 1,447 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Acevedo for performance year 2024, reported as part of a group. Dr. Acevedo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Acevedo as offering telehealth.

Dmand AI links 1 paper to Dr. Acevedo in 2009. Dr. Acevedo's most frequent co-authors are Carlos A. Encarnacion, MD, Kristi Jo McIntyre, MD and Joyce Ann O'Shaughnessy, MD.

Dmand AI links Dr. Acevedo to 1 clinical trial. Conditions studied include Carcinoma, Renal Cell and Kidney Neoplasms.

CMS Open Payments shows 1,244 general payments to Dr. Acevedo from 92 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,583.

Dmand AI lists 1 award for Dr. Acevedo, most recently CMS Stage 1 EHR in 2014.

Dr. Acevedo graduated from Sidney Kimmel Medical College in 1998.

Dr. Acevedo is in network with 18 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.